Chemo-phosphoproteomic profiling with ATR inhibitors berzosertib and gartisertib uncovers new biomarkers and DNA damage response regulators.
Jadav R, Weiland F, Noordermeer SM, Carroll T, Gao Y, Wang J, Zhou H, Lamoliatte F, Toth R, Macartney T, Brown F, Hastie CJ, Alabert C, van Attikum H, Zenke F, Masson JY, Rouse J.
Jadav R, et al. Among authors: brown f.
Mol Cell Proteomics. 2024 Jun 14:100802. doi: 10.1016/j.mcpro.2024.100802. Online ahead of print.
Mol Cell Proteomics. 2024.
PMID: 38880245
Free article.